Japan· JP-3999001Q1051
ラクツロース
A lactulose product containing ラクツロース, registered in Japan by 興和, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Lactulose is registered in 16 of 19 countries.
Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Lactulose · ATC A06AD11
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ラクツロース
- Manufacturer
- 興和
- Country
- Japan (JP)
- ATC code
- A06AD11
- ATC class
- Lactulose
- Defined daily dose
- 12.5 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
657 interactions on record for lactulose.
Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lactulose · interactions on record
657 records
- 263 moderate
- 18 minor
- 376 info
Most severe, free to view
- CisaprideA03FA02moderate
- OndansetronA04AA01moderate
- GranisetronA04AA02moderate
- DolasetronA04AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A06AD11
Lactulose, as other registers publish it.
- NetherlandsAlbert Heijn Laxeerdrank Lactulose 667 mg/ml, stroopHealthypharm B.V.
- GermanyBifiteralCooper Consumer Health Deutschland Gmbh
- United KingdomBifiteral 10g oral powder sachetsImported (Germany)
- BelgiumBifiteral 66.7 g/100 mlCooper Consumer Health
- GermanyBifiteral Mit PflaumenaromaCooper Consumer Health B.V.
- GermanyBifiteral Mit PflaumenaromaViatris Healthcare Gmbh
- IrelandBrillphalac 3.335 g/5 ml oral solutionBrillpharma (Ireland) Limited
- United StatesConstuloseActavis Pharma, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/caf897d7-1082-40c9-993f-4cb74f735495 GET /v1/drugs/caf897d7-1082-40c9-993f-4cb74f735495?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "６０％１ｍＬ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999001Q1051",
"category": "内用薬",
"price_yen": 7.1,
"generic_name": "ラクツロース",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about lactulose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.